Ertugliflozin: Cardioprotective Effects on Epicardial Fat

Clinical trial NCT04167761 · COMPLETED

Trial details

NCT number: NCT04167761
Sponsor: Stanford University
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Cardiovascular Diseases Atherosclerosis Type 2 Diabetes Insulin Resistance

Start date: 2020-07-01
Primary completion: 2023-12-31
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.